Biogen (BIIB)

Biogen (BIIB) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• BIIB last traded at $248.97, -1.83% on the day.
• Biogen: market cap $37.49B, P/E 105.4, revenue $10.30B over the last four quarters, next earnings 2027-02-05.
• Over the past year BIIB returned 66.41%; year to date 41.47%.

Updated 2026-11-02 18:38 UTC